硼替佐米治疗复发多发性骨髓瘤致肿瘤溶解综合征1例
Journal of Internal Intensive Medicine(2020)
Abstract
多发性骨髓瘤(multiple myeloma,MM)是仅次于非霍奇金淋巴瘤的第二常见恶性血液病,常伴有多发性溶骨性损害、高钙血症、贫血、肾脏损害,目前为不可治愈的疾病[1].硼替佐米作为第一代蛋白酶抑制剂,已成为治疗MM的基石性药物[2],除引起常见的外周神经病变等并发症外,比传统化疗药物更安全,罕见引起肿瘤溶解综合征(tumor lysis syndrome,TLS).本文报道1例硼替佐米治疗复发的MM所致TLS.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined